Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Alifano

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Revue Des Maladies Respiratoires|November 19, 2005
[Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumors]C Perrotin, P Lemeunier, D Grahek, et al.
British Journal of Cancer|June 7, 2012
FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancerY Cimino, A Costes, D Damotte, et al.
Diagnostic and Interventional Imaging|November 7, 2015
Solitary fibrous tumor of the pleura: Can computed tomography features help predict malignancy? A series of 56 patients with histopathological correlatesS Hélage, M P Revel, M L Chabi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2015
Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancerJ Michels, J Adam, A Goubar, et al.
Revue De Pneumologie Clinique|October 23, 2018
[IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era?]C Hamard, X Mignard, N Pecuchet, et al.
Revue Des Maladies Respiratoires|June 8, 2011
[Effect of tinzaparin on survival in non-small-cell lung cancer after surgery. TILT: tinzaparin in lung tumours]G Meyer, B Besse, S Friard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinomaP Hofman, M Ilie, V Hofman, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2020
Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinomaG Boulle, Y Velut, A Mansuet-Lupo, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Revue Des Maladies Respiratoires|November 19, 2005
[Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumors]C Perrotin, P Lemeunier, D Grahek, et al.
British Journal of Cancer|June 7, 2012
FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancerY Cimino, A Costes, D Damotte, et al.
Diagnostic and Interventional Imaging|November 7, 2015
Solitary fibrous tumor of the pleura: Can computed tomography features help predict malignancy? A series of 56 patients with histopathological correlatesS Hélage, M P Revel, M L Chabi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2015
Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancerJ Michels, J Adam, A Goubar, et al.
Revue De Pneumologie Clinique|October 23, 2018
[IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era?]C Hamard, X Mignard, N Pecuchet, et al.
Revue Des Maladies Respiratoires|June 8, 2011
[Effect of tinzaparin on survival in non-small-cell lung cancer after surgery. TILT: tinzaparin in lung tumours]G Meyer, B Besse, S Friard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinomaP Hofman, M Ilie, V Hofman, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2020
Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinomaG Boulle, Y Velut, A Mansuet-Lupo, et al.
Pageof 6